IDXX

IDEXX Laboratories, Inc.

$696.64

-1.42%
SectorHealthcareIndustryDiagnostics & ResearchCountryUnited States

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E.

Source: Yahoo Finance
AI summary

Price & performance

1M+29.6%
3M+18.4%
YTD+0.3%
1Y-7.0%
52-week range—
Beta0.96
Full chart and returns against a benchmark

Q-Score

70/ 100

Quality against peers; 50 is the peer median.

Growth60
Risk72
Performance53
Valuation36
Profitability96
Leverage73
Sentiment52
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$4.3B+10.4%
Net income$1.1B+19.3%
Net margin24.6%+1.8 pts
Historical fundamentals

Revenue exposure

36%of revenue from outside the US
United States64%
Europethe Middle Eastand Africa Other5%
Germany5%
Regions, segments, customers and suppliers

Valuation

IDXXIndustryP/E46.4341.31P/S11.775.66EV/EBITDA33.0931.63P/B29.364.91PEG3.083.59
Dividend yield0.00%
Every valuation metric

Earnings

Feb 1next report, before the open
EPS estimate$3.70
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate